TY - JOUR
T1 - Rates of glucagon activation and deactivation of hepatic glucose production in conscious dogs
AU - Dobbins, Robert L.
AU - Davis, Stephen N.
AU - Neal, Doss
AU - Caumo, Andrea
AU - Cobelli, Claudio
AU - Cherrington, Alan D.
PY - 1998
Y1 - 1998
N2 - To determine the time course of glucagon activation and deactivation of hepatic glucose production (HGP), studies were conducted in 18-hour fasted, conscious dogs. Somatostatin was infused with insulin replaced intraportally at 1.8 pmol μ kg-1 · min-1 and glucagon replaced peripherally at 1.0 ng · kg-1 · min-1. After a 2-hour control period, glucagon infusion was either (1) increased fourfold for 4 hours (GGN 4X), (2) increased fourfold for 30 minutes and returned to a basal rate for 3.5 hours (GGN 4X/1X), or (3) fixed at the basal rate for 4 hours (GGN 1X). In the latter two protocols, glucose was infused peripherally to match glucose concentrations observed during GGN 4X. Glucose turnover was determined by deconvolution with the impulse response of the glucose system described by a two-compartment, time- varying model identified from high-performance liquid chromatography (HPLC)- purified [3-3H]glucose tracer data. In GGN 4X, HGP was stimulated from 15.2 ± 0.9 μmol · kg-1 · min-1 to 52.7 ± 6.5 μmol · kg-1 · min-1 after just 15 minutes, but it decreased over the subsequent 3 hours to a rate 25% above basal. In GGN 4X/1X, the increase in HGP during the first 30 minutes equaled that observed in GGN 4X, but when glucagon infusion was returned to basal, HGP decreased in 15 minutes to rates equal to those observed in GGN 1X. The times for half-maximal activation and deactivation of glucagon action were equal (4.5 ± 1.0 and 4.0 ± 1.1 minutes, respectively). The very rapid and sensitive hepatic response to glucagon makes pancreatic glucagon release a key component of minute-to-minute glucose homeostasis.
AB - To determine the time course of glucagon activation and deactivation of hepatic glucose production (HGP), studies were conducted in 18-hour fasted, conscious dogs. Somatostatin was infused with insulin replaced intraportally at 1.8 pmol μ kg-1 · min-1 and glucagon replaced peripherally at 1.0 ng · kg-1 · min-1. After a 2-hour control period, glucagon infusion was either (1) increased fourfold for 4 hours (GGN 4X), (2) increased fourfold for 30 minutes and returned to a basal rate for 3.5 hours (GGN 4X/1X), or (3) fixed at the basal rate for 4 hours (GGN 1X). In the latter two protocols, glucose was infused peripherally to match glucose concentrations observed during GGN 4X. Glucose turnover was determined by deconvolution with the impulse response of the glucose system described by a two-compartment, time- varying model identified from high-performance liquid chromatography (HPLC)- purified [3-3H]glucose tracer data. In GGN 4X, HGP was stimulated from 15.2 ± 0.9 μmol · kg-1 · min-1 to 52.7 ± 6.5 μmol · kg-1 · min-1 after just 15 minutes, but it decreased over the subsequent 3 hours to a rate 25% above basal. In GGN 4X/1X, the increase in HGP during the first 30 minutes equaled that observed in GGN 4X, but when glucagon infusion was returned to basal, HGP decreased in 15 minutes to rates equal to those observed in GGN 1X. The times for half-maximal activation and deactivation of glucagon action were equal (4.5 ± 1.0 and 4.0 ± 1.1 minutes, respectively). The very rapid and sensitive hepatic response to glucagon makes pancreatic glucagon release a key component of minute-to-minute glucose homeostasis.
UR - http://www.scopus.com/inward/record.url?scp=0031882591&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031882591&partnerID=8YFLogxK
U2 - 10.1016/S0026-0495(98)90209-8
DO - 10.1016/S0026-0495(98)90209-8
M3 - Article
C2 - 9472959
AN - SCOPUS:0031882591
VL - 47
SP - 135
EP - 142
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
SN - 0026-0495
IS - 2
ER -